m6A is a critical regulator in glioblastoma and loss of METTL3 is beneficial to radiosensitivity of disease cells (Cui et al., 2017; Dong & Cui, 2020; Li et al., 2019; Zhang et al., 2017). Here, METTL3 is linked to glioblastoma.